Morgan Stanley Maintains Overweight on Compass Pathways, Raises Price Target to $18

Benzinga · 1d ago
Morgan Stanley analyst Judah Frommer maintains Compass Pathways (NASDAQ:CMPS) with a Overweight and raises the price target from $17 to $18.